Logout
If you want to log out click in LogOut
LncRNA qPCR challenges are a major concern in gene expression studies, especially when analyzing low-abundance, isoform-dependent or structurally complex transcripts.
Because long non-coding RNAs can present weak expression signals, transcript variability and genomic overlap, reliable qPCR analysis requires validated assays, careful primer design and optimized experimental workflows.
Compared with many protein-coding genes, lncRNAs present specific analytical difficulties that can affect qPCR specificity, sensitivity and reproducibility.
These difficulties are mainly linked to low expression levels, transcript isoforms, genomic overlap and variable annotation across databases.
Many lncRNAs are expressed at very low levels, which can generate weak amplification signals, increased variability and reduced reproducibility.
Solution: use sensitive assays, optimize qPCR conditions and consider pre-amplification when RNA input or transcript abundance is limited.
LncRNAs may have multiple transcript variants, which can affect primer placement and make expression results difficult to interpret.
Solution: check transcript annotation, target appropriate transcript regions and use validated assays whenever possible.
Some lncRNAs overlap protein-coding genes or regulatory regions, increasing the risk of cross-amplification or non-specific signal.
Solution: apply careful primer design, include genomic DNA management and experimentally validate assay specificity.
LncRNA annotation can vary between databases, which may lead to inconsistent target selection or assay interpretation.
Solution: verify the selected target sequence, transcript model and biological relevance before assay design.
Poor reference gene selection can distort lncRNA expression analysis, especially across different tissues, treatments or sample types.
Solution: use reference genes adapted to the experimental model and validate normalization stability when possible.
FFPE, LCM, single-cell or low-input RNA samples may be limited, degraded or difficult to analyze with standard workflows.
Solution: adapt reverse transcription, qPCR conditions and pre-amplification strategy to the sample constraints.
Low-expression lncRNAs are one of the most frequent challenges in lncRNA qPCR analysis. Weak signal intensity can increase technical variability and make interpretation less reliable.
For very low-abundance targets or limited RNA input, qPCR pre-amplification can support detection before targeted qPCR analysis.
SpeAmp® pre-amplification kits can support workflows involving low-expression lncRNAs, rare samples, FFPE material, LCM samples or limited RNA input.
AnyGenes® supports lncRNA qPCR projects with validated assays, qPCR arrays, custom panels and scientific guidance for complex RNA targets.
Assays designed to support specific detection of selected long non-coding RNA targets.
96- and 384-well qPCR formats for focused lncRNA screening and multi-target expression studies.
Panels designed from your selected lncRNA targets, biological model and research objectives.
Assay design adapted to transcript structure, specificity and reproducible qPCR analysis.
SpeAmp® pre-amplification can support difficult samples and low-abundance RNA targets.
Support for assay selection, workflow optimization and interpretation of lncRNA qPCR results.
Several experimental design issues can increase variability or reduce confidence in lncRNA qPCR results.
Non-validated primers can increase the risk of non-specific amplification, especially for complex lncRNA targets.
RNA-seq data, primer design and qPCR interpretation should be aligned with the relevant transcript region.
Genomic DNA contamination can affect qPCR interpretation when targets overlap genomic or coding regions.
Reference genes should be appropriate for the sample type, biological condition and experimental design.
Insufficient biological or technical replication can reduce confidence in weak-expression qPCR results.
Low-input, degraded or rare samples may require optimized reverse transcription, qPCR or pre-amplification steps.
LncRNA qPCR analysis requires a more rigorous strategy than many standard gene expression studies because many targets are weakly expressed, structurally complex or difficult to distinguish from overlapping genomic regions.
For low-abundance or isoform-dependent transcripts, validated assays and optimized workflows are essential to support specificity, reproducibility and biologically meaningful interpretation.
Low expression, isoforms and genomic overlap can affect specificity, sensitivity and reproducibility.
Weakly expressed lncRNAs may require sensitive assays, optimized qPCR conditions or pre-amplification.
Primer design should consider isoforms, target region and potential overlap with coding genes.
Validated lncRNA qPCR assays help improve specificity and reproducibility in complex RNA analysis.
Whether you are facing specificity issues, weak amplification signals or low-input sample constraints, AnyGenes® can help you select validated lncRNA qPCR assays and adapt the workflow to your research project.
LncRNA qPCR can be difficult because many lncRNAs are weakly expressed, may have multiple transcript isoforms and can overlap genomic or coding regions.
The main challenges include low expression levels, isoform complexity, genomic overlap, annotation variability, normalization and limited RNA input.
Specificity can be improved by using validated assays, checking transcript annotation, designing primers carefully and validating assay performance experimentally.
Low-expression lncRNAs can be analyzed using sensitive assays, optimized qPCR conditions and, when appropriate, pre-amplification strategies such as SpeAmp®.
Standard qPCR assays should only be used if they are carefully designed and validated for the selected lncRNA target. Validated assays are recommended for complex, overlapping or weakly expressed lncRNAs.
Yes. AnyGenes® can support assay selection, custom qPCR panel design, low-input workflows and experimental strategy for lncRNA qPCR projects.